Loring Wolcott & Coolidge Fiduciary Advisors LLP Haleon PLC Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Haleon PLC stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 950 shares of HLN stock, worth $8,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
950
Previous 950
-0.0%
Holding current value
$8,768
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HLN
# of Institutions
640Shares Held
426MCall Options Held
82KPut Options Held
27.3K-
Dodge & Cox San Francisco, CA177MShares$1.63 Billion0.92% of portfolio
-
Clearbridge Investments, LLC New York, NY38.4MShares$355 Million0.27% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa14.4MShares$133 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA13.4MShares$124 Million0.02% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il13.2MShares$121 Million0.02% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $42.6B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...